Delivery Order SPE2DB22D9367-SPE2DB25FSX88

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $111K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 contract is for the supply of the drug TRIKAFTA 50-25-37.5 MG/75 MG to the Defense Logistics Agency (DLA), the agency responsible for providing logistics, acquisition, and technical services to the U.S. military. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price contract is for the supply of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, valued at $37,053.68, is for the supply of a pharmaceutical product called TRIKAFTA 100-50-75 MG/150 MG UU 84S. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, that allows DMS Pharmaceutical Group to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $18,318.75 contract provides for the delivery of TRIKAFTA 100-50-75 MG/150 MG medication over a period ending on November 16, 2023. This is an order under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA to supply a comprehensive range of pharmaceutical products to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $36,976.24, is for the delivery of TRIKAFTA 100-50-75 MG/150 MG tablets. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $88,514.90 contract is for the delivery of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a specialized prescription medication. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $37,053.68, is for the delivery of TRIKAFTA 100-50-75 MG/150 MG medication. This order is issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to place delivery orders for a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of the pharmaceutical product TRIKAFTA 100-50-75 MG/150 MG UU 84S. The potential value of the contract is $194,275.62, and the completion date is September 30, 2022. This delivery order is placed against a larger indefinite delivery contract between DMS Pharmaceutical Group Inc. and the...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical product, with an ultimate completion date of April 8, 2024. The award is made under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24D9210 with DLA, valued up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,488.12 contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB25FSX88
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $110,900.52, is for the supply of TRIKAFTA 100-50-75 MG/150 MG pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. The contract has no set-aside designation, and DMS Pharmaceutical Group has consistently secured federal contracts without specific set-aside requirements, leveraging its status as a woman-owned small business.

Generated 7/29/25, 9:42 AM